ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...
Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...
Patients in Canada may have to wait longer to access generic versions of Ozempic because of continuing delays in processing of new drug submissions at Health Canada, according to Swiss generic drug ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
A generic drug is a drug that can be manufactured and sold by any company, as long as they meet the stringent criteria for purity as required by Health Canada. It is usually sold under a generic name, ...
The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...
Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. For the first time, a generic GLP-1 has been approved by ...
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...
Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. Monday, Viatris and Amphastar Pharmaceuticals both said they have received the FDA’s ...